Join the discussion.

STAY UP TO DATE ON THE MOST IMPORTANT ISSUES IN GENETICS TODAY.

Upcoming Webinars

Challenging variant types detected by next-generation sequencing and their contribution to monogenic disease

Challenging variant types detected by next-generation sequencing and their contribution to monogenic disease
Swaroop Aradhya, PhD, FACMG, and Dianalee McKnight, PhD, FACMG (Medical Affairs, Invitae)
June 09, 2020
9 a.m. PST - 10 a.m. PST
Register Now

NGS has revolutionized genetic testing, but not all NGS approaches are the same. Some may suffer from limitations that reduce or eliminate their sensitivity to certain types of technically challenging variants, and the prevalence of these are not widely understood.

Please join us as we discuss the important aspects of NGS assay design and bioinformatics that can influence analytical sensitivity for a broad spectrum of variant types.

The program, focused on the detection of complex variants, will help learners:

1. Define the types and prevalence of variants that are challenging to detect by next-generation sequencing;

2. Examine aspects of clinical genetic test design that can aid in the accurate detection of challenging variants.


An in-depth discussion of Invitae's sponsored testing programs: What you need to know

An in-depth discussion of Invitae's sponsored testing programs: What you need to know
Michelle Fox (MS, LCGC), Michael Hamilton (Chief Privacy Officer), and Gautam Mehta (Commercial Partnerships)
June 16, 2020
9 a.m. PST - 10 a.m. PST
Register Now

If you missed our sponsored testing webinar last October, this is your chance to see an updated version and have all your questions answered. Our experts will discuss the details of Invitae's sponsored, no-charge testing programs. They will outline the structure and benefits of the programs and discuss how they are designed to increase access to genetic testing. We will also dive into Invitae's de-identified data sharing policies and share how we protect your patient's personal information. Finally, we will discuss the benefits of the Detect family of sponsored testing programs.


Eligiendo la prueba correcta para el paciente: selección de secuenciación por exoma y paneles genéticos

Eligiendo la prueba correcta para el paciente: selección de secuenciación por exoma y paneles genéticos
Ana Morales, MS, CGC (Consejera Genética, Invitae), Dianalee McKnight, PhD, FACMG (Directora de Asuntos Médicos, Clínica Emergente Omics, Invitae)
June 16, 2020
11 a.m. PST - noon PST
Register Now

Seleccionar la prueba genética adecuada para sus pacientes puede ser difícil, especialmente para presentaciones clínicas complejas. Entienda cómo hacerlo con la Consejera Genética Ana Morales mientras discute:
1. Elegir la prueba genética adecuada para su paciente, desde pruebas de un solo gen hasta exomas
2. Maximizar el rendimiento diagnóstico de la secuenciación del exoma
3. Las opciones de pruebas de alta calidad y bajo costo de Invitae, incluidos los programas patrocinados de pruebas
4. Simplificando el proceso de prueba con pedidos en línea y soporte de telemedicina


Recent Webinars

Genetic testing: A cost-effective and accurate diagnostic tool for immunology patients

Britt Johnson, PhD, FACMG (Medical Affairs, Invitae)
June 02, 2020
View Recording

In this webinar, intended for immunologists, Dr. Britt Johnson will share:
1. Information about genetic testing as a direct, cost-effective, and accurate diagnostic tool for your patients
2. How Invitae helps clinicians translate genetic information into meaningfully better care for patients, including:
- high-quality test options, such as the Invitae Primary Immunodeficiency Panel
- family variant testing, which helps ensure relatives who should get tested do get tested: if Invitae finds that your patient has a pathogenic or likely pathogenic variant, we offer testing to relatives for that same variant at no additional charge
- $250 USD patient-pay option for Invitae testing
3. Learn how to access a sponsored testing program, which provides genetic testing with the Invitae Severe Congenital Neutropenia Panel at no charge for eligible patients
4. Review Invitae’s telehealth solutions, which help patients and providers continue to access genetic testing remotely in the current public health climate.


Invitae's biopharma partnerships can help connect patients to the right treatments faster

Daniel Anderson and Gautam Mehta (Commercial Partnerships, Invitae)
May 19, 2020
View Recording

In this live webinar, Daniel Anderson and Gautam Mehta will discuss the details of Invitae's genetic testing partnerships and how they can:

1. Remove barriers to testing, allowing patients to receive an accurate diagnosis quicker
2. Inform patients and clinicians of clinical trial and treatment opportunities
3. Confirm positive diagnoses and suspected cases with genetic testing
4. Accelerate enrollment in clinical trials
5. Help clarify the natural history of disease using patient-reported outcomes and clinical records


Early genetic testing: A cost-effective and accurate tool to aid epilepsy diagnosis

Dianalee McKnight, PhD, FACMG (Medical Affairs, Invitae)
May 19, 2020
View Recording

In this webinar, intended for pediatric neurologists and epilepsy specialists, Dr. Dianalee McKnight will share:

1. How early genetic testing can be used as a direct, cost-effective, and accurate diagnostic tool for patients with epilepsy
2. Information on Invitae’s comprehensive, high-quality approach to genetic testing, including our laboratory technology and flexible ordering options
3. How to access the 180+ gene Invitae Epilepsy Panel at no cost for eligible patients from 0-8 years of age through a sponsored testing program
4. Review Invitae’s telehealth solutions, which allows patients and providers to access genetic testing remotely during the current public health climate


Integrating functional modeling to enhance clinical variant interpretation

Dr. Bob Nussbaum (Chief Medical Officer, Invitae); Dr. Britt Johnson (Medical Director, Metabolic Genetics and Immunology. Medical Affairs Director, Biopharma Partnerships, Invitae)
April 29, 2020
View Recording

The program, intended for genetic counselors, geneticists, and other healthcare providers (in the EMEA time zone), will help learners to:

1. Define the limitations of existing approaches to address variants of uncertain significance in variant interpretation
2. Evaluate the validity and clinical application of robust, quantitative, and scalable functional modeling approaches to variant classification


Functional modeling: The next frontier in variant interpretation

Keith Nykamp, PhD, Invitae; Douglas M. Fowler, PhD, University of Washington School of Medicine; Carlos Araya, PhD, Invitae
April 09, 2020
View Recording

Join us as we discuss the challenges of variants of uncertain significance (VUS) in the clinical setting and demonstrate the role of functional modeling in addressing some of these challenges. This in-depth presentation will provide insight for both those who watched our previous functional modeling webinar as well as anyone new to the subject.

The webinar will help you:
1. Understand how often to expect VUS results and the traditional approaches to VUS resolution
2. Describe the role of functional modeling as an additional evidence type that can assist in variant classification
3. Define different functional approaches and their application to specific variant types


Integrating functional modeling to enhance clinical variant interpretation

Robert L. Nussbaum, MD, Chief Medical Officer, Invitae; Swaroop Aradhya, PhD, FACMG, Head of Global Medical Affairs, Invitae
April 02, 2020
View Recording

The program, intended for genetic counselors, geneticists, and other healthcare providers (in the Asia-Pacific time zones) interested in variant classification, will help learners:

1. Define the limitations of existing approaches to address variants of uncertain significance in variant interpretation
2. Evaluate the validity and clinical application of robust, quantitative, and scalable functional modeling approaches to variant classification


Invitae Boosted Exome: Providing affordable, transparent, clinically relevant results

Heather McLaughlin, PhD, FACMG, Medical Director, Invitae
April 02, 2020
View Recording

In this webinar (for clinicians in the EMEA time zone), Heather McLaughlin, PhD, FACMG, will provide an in-depth discussion of the Invitae Boosted Exome, including patient selection, ordering tips, coverage performance, and how Invitae's rigorous analysis is informed by the patient's phenotype and genotype.